This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
See Cramer's multi-million dollar portfolio for FREE and get his new book Get Rich Carefully! Learn More

5 Stocks Flashing Insider-Buying Alerts

Ligand Pharmaceuticals

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

One name in the biotechnology and drugs sector where insiders have been very active in is Ligand Pharmaceuticals (LGND). This is a biotechnology company that focuses on drug discovery and early-stage development of pharmaceuticals that address critical unmet medical needs or those that more effective and/or safer than existing therapies. This is a very interesting insider buy since an executive is paying up to own the stock with shares up over 70% so far in 2011.

This company has a market cap of $301 million and an enterprise value of $317 million. This stock trades at a very rich valuation, since their trailing price-to-earnings is 250 and their forward price-to-earnings is 95. Ligand's estimated growth rate for this year is 214% and for next year it's pegged at -78.1%. This company has a bit more debt on their books than cash, since their total cash position is $13.44 million and total debt is $30.11 million.

A director just bought 61,559 shares, or $805,350 worth of stock, between $12.54 and $14.21 per share. This same director has been steadily buying up shares of Ligand in August that now have totaled over $4 million worth of stock.

From a technical standpoint, this is in a very strong uptrend with shares trading well above both its 50-day and 200-day moving averages. This stock has been displaying a very bullish pattern for all of this year with shares making higher highs and higher lows. This shows that large traders have been paying up to buy this stock anytime it has pulled back. The stock also recently broke out above some past resistance at $14.80 a share on big volume.

If you're looking to buy this stock, I would let this name come in a bit since the relative strength index is over 70 which often times marks an overbought reading on any stock. Let this name pullback toward $14 or possible $13.50 a share before you jump in. If it doesn't pullback that much, then you could be a buyer as long as it holds above the key breakout level of $14.80.

Stock quotes in this article: ECL, MWW, RCL, LGND, HOGS, ATSG, QNST, MHGC 

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
DOW 16,408.54 -16.31 -0.10%
S&P 500 1,864.85 +2.54 0.14%
NASDAQ 4,095.5160 +9.2910 0.23%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto
Advertising Partners

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs